As of 2025-05-17, the Relative Valuation of 89Bio Inc (ETNB) is (37.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.64 USD, the upside of 89Bio Inc based on Relative Valuation is -595.8%.
The range of the Relative Valuation is (28.61) - (48.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 18.2x | 14.0x |
| Forward P/E multiples | 10.8x - 20.4x | 14.6x |
| Fair Price | (28.61) - (48.31) | (37.88) |
| Upside | -474.4% - -732.4% | -595.8% |
| Date | P/E |
| 2025-05-15 | -2.88 |
| 2025-05-14 | -3.10 |
| 2025-05-13 | -2.94 |
| 2025-05-12 | -3.06 |
| 2025-05-09 | -2.91 |
| 2025-05-08 | -2.94 |
| 2025-05-07 | -2.90 |
| 2025-05-06 | -2.93 |
| 2025-05-05 | -3.25 |
| 2025-05-02 | -3.30 |
| 2025-05-01 | -3.07 |
| 2025-04-30 | -3.03 |
| 2025-04-29 | -2.85 |
| 2025-04-28 | -2.79 |
| 2025-04-25 | -2.62 |
| 2025-04-24 | -2.60 |
| 2025-04-23 | -2.50 |
| 2025-04-22 | -2.47 |
| 2025-04-21 | -2.37 |
| 2025-04-17 | -2.29 |
| 2025-04-16 | -2.22 |
| 2025-04-15 | -2.28 |
| 2025-04-14 | -2.23 |
| 2025-04-11 | -2.09 |
| 2025-04-10 | -1.89 |
| 2025-04-09 | -2.09 |
| 2025-04-08 | -1.82 |
| 2025-04-07 | -2.07 |
| 2025-04-04 | -2.18 |
| 2025-04-03 | -2.59 |
| 2025-04-02 | -2.71 |
| 2025-04-01 | -2.57 |
| 2025-03-31 | -2.74 |
| 2025-03-28 | -3.05 |
| 2025-03-27 | -3.38 |
| 2025-03-26 | -3.03 |
| 2025-03-25 | -3.02 |
| 2025-03-24 | -3.45 |
| 2025-03-21 | -3.22 |
| 2025-03-20 | -3.30 |
| 2025-03-19 | -3.32 |
| 2025-03-18 | -3.23 |
| 2025-03-17 | -3.28 |
| 2025-03-14 | -3.20 |
| 2025-03-13 | -3.09 |
| 2025-03-12 | -3.15 |
| 2025-03-11 | -2.85 |
| 2025-03-10 | -2.70 |
| 2025-03-07 | -2.96 |
| 2025-03-06 | -3.14 |